EAU 2018 Prostate Cancer - Results from #42

Viewing 43-62 of 87 articles

EAU 2018: mCRPC New Drugs and Sequencing

EAU 2018: Prostate MRI Combined with PSA-Density May Reduce the Number of Follow-Up Targeted Biopsies in Men on Active Surveillance for Low-Risk Prostate Cancer

EAU 2018: Prostate-Specific Antigen Response in Men with Nonmetastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: Results from PROSPER

EAU 2018: Using Clues from Studies of Genomic Evolution to Develop Clinically Applicable Biomarkers

EAU 2018: Local Control is Needed

EAU 2018: Systemic Therapy is the Standard of Care

EAU 2018: Clinical Data and Imaging are Doing the Job

EAU 2018: Clinical Data and Imaging are Doing the Job

EAU 2018: Genomic Screening Should Be Done

EAU 2018: Local and Metastasis Imaging Targeted Treatments are Needed

EAU 2018: Socioeconomic Status and Diagnosis, Treatment, and Mortality in Men with Prostate Cancer: A Nationwide Population-Based Study

EAU 2018: Development of PSA Screening Nomograms for 15-Year Prediction of Prostate Cancer Diagnosis, Mortality, and All-Cause Mortality

EAU 2018: The German Risk-Adapted Prostate Cancer Screening Trial (PROBASE): First Results After Recruitment of 30,000 Men

EAU 2018: Holmium Laser Enucleation of the Prostate (HoLEP) in Large-Sized Prostates

EAU 2018: Tumor-Associated Macrophages in Prostate Biopsy Determined by Automated Image Analysis - Independent Prognostic Marker for Biochemical Recurrence in Prostate Cancer Patients

EAU 2018: Urinary Steroidal Profile as Innovative and Not Expensive Tool in Differential Diagnosis Between Benign Prostate Hyperplasia and Prostate Carcinoma

EAU 2018: Defining a Favorable Intermediate-Risk Group: Utility of Magnetic Resonance Imaging and Genetic Tests

EAU 2018: Support of Robot-assisted Salvage Lymph Node Dissection For Clinically Recurrent Prostate Cancer

EAU 2018: Neutrophil to Lymphocyte Ratio is Associated with Lymph Node Invasion and Higher Nodal Burden in Contemporary High-Risk Patients

EAU 2018: Prediction of Significant Prostate Cancer in Patients with Previously Negative Prostate Biopsy Undergoing MRI/Ultrasound-Fusion Biopsy in Combination with Systematic Biopsy

1
2
3
4
5